Angelakis P, Throuvalas N, Paraskevas G, Pontifix G
Br J Radiol. 1975 May;48(569):390-1. doi: 10.1259/0007-1285-48-569-390.
This paper reports the results of a prospective clinical trial comparing 200 rads daily five times weekly for four weeks with 400 rads twice weekly for four weeks. Total dose in the first case was 4,000 rads and in the second 3,200 rads. Thirty patients threated palliatively for bronchial carcinoma are involved in this report. Treatment was given at 220 kV and the intensity of skin erythema at the end of the treatment was the measure of comparison. Generally 200 rads daily five times weekly for four weeks produced more intense erythema than the other scheme used.
本文报告了一项前瞻性临床试验的结果,该试验比较了每周5次、每次200拉德,共四周的放疗方案与每周2次、每次400拉德,共四周的放疗方案。第一种方案的总剂量为4000拉德,第二种方案为3200拉德。本报告涉及30例接受支气管癌姑息治疗的患者。治疗在220千伏下进行,以治疗结束时皮肤红斑的程度作为比较指标。一般来说,每周5次、每次200拉德,共四周的放疗方案比所采用的另一种方案产生的红斑更严重。